Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ANDAs By The Numbers: Metrics Look Good – But Review Processes Need Attention Too

Jan 11 2018

• By Cole Werble

Related Content

Want To Avoid A Refuse-To-File? Submit ANDA In English, FDA Says

Jan 04 2018

Gottlieb Places Drug Pricing Out Front In First Speech To US FDA Staff

May 16 2017

FDA Ends ANDA 'Reviews' To Streamline Approval Process

Jan 04 2018

In Switching Generic 'Reviews' To 'Assessments' Is US FDA Changing More Than Just A Word?

Jan 11 2018

Additional Topics

United States Generic Drugs Drug Review Regulation FDA BioPharmaceutical

More from Generics

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window